BlockchainFX ($BFX) presale at $0.021 nears sellout with 6,650+ buyers. $2K could turn into $95K at $1, making it 2025’s best crypto presale pick.BlockchainFX ($BFX) presale at $0.021 nears sellout with 6,650+ buyers. $2K could turn into $95K at $1, making it 2025’s best crypto presale pick.

How $2K in BlockchainFX Could Multiply Into $95K in the Best Crypto Presale of 2025

bull

Are you tired of switching between endless apps to trade crypto, stocks, forex, and commodities? Imagine one seamless platform that not only lets you trade everything in one place but also pays you rewards daily as you trade. That’s precisely what BlockchainFX ($BFX) delivers. Positioned as the best crypto presale of 2025, BlockchainFX is redefining what it means to be a trader in both digital and traditional finance.

image 108

This isn’t just another exchange; BlockchainFX is the world’s first crypto-powered multi-asset super app, designed to bridge DeFi and TradFi. With its presale heating up, now may be your last chance to secure early access before launch and ride the wave of 100x+ gains.

Why BlockchainFX Is the Future of Trading

BlockchainFX is the first crypto-powered multi-asset super app that lets you trade over 500+ assets in one place. From Bitcoin, Ethereum, and meme coins to global stocks, forex pairs, ETFs, bonds, commodities, and futures like gold and oil, everything is available within a single platform. No more juggling between multiple exchanges, BlockchainFX provides a seamless, unified hub for all your trading needs.

Beyond convenience, BlockchainFX is designed to generate daily passive income for users. Up to 70% of trading fees are redistributed to token holders, with rewards paid automatically in both BFX and USDT. Whether you’re actively trading or simply holding tokens, the platform ensures your portfolio is constantly working for you. Add in low transaction fees, and traders can maximize their profits while minimizing costs, creating a win-win ecosystem.

Speed and security further distinguish BlockchainFX. With instant asset swaps, you can switch between crypto, stocks, or gold in seconds, without delays or restrictions. At the same time, security remains a top priority. The platform has been independently audited by Coinsult and CertiK, providing users with peace of mind that their funds and data are protected to the highest level.

image 109

The BFX Presale: Record-Breaking Momentum

Here’s why the BlockchainFX presale is gaining traction as the best crypto presale of 2025:

  • Raised so far: $6,253,200 (96.20% of $6.5M soft cap)
  • Participants: 6,650 investors and growing
  • Presale price: $0.021 (confirmed launch at $0.05)
  • Bonus: Use code AUG35 to get +35% tokens
  • Payment options: ETH, USDT (ERC-20, TRC-20, BEP-20, Solana), Bitcoin, and more

This is not just token speculation; it’s an early entry into a platform that will pay users back daily.

Investment Potential: Turning $2,000 Into $95,000

If you invest $2,000 at $0.021, you’ll receive ~95,238 BFX tokens. Here’s the math:

  • At Launch ($0.05): Value ≈ $4,761 → +138% gain
  • At $1 BFX: Value ≈ $95,238 → +4,700% gain

That’s the power of getting in early. Even a relatively modest $2,000 investment has the potential to deliver life-changing upside as BlockchainFX scales globally.

Why Acting Now Is Critical

The presale price is locked at $0.021, but once BFX lists at $0.05, you’ve already doubled your money. Factor in daily staking rewards and the potential long-term climb to $1+ per token, and you’re looking at a generational wealth opportunity.

With thousands of investors already on board, the window is closing fast. The presale is nearly sold out, and the AUG35 bonus code won’t last forever.

image 110

Final Call: Secure Your BFX Before It’s Gone

Time is running out, and the BlockchainFX presale is quickly approaching its final stages. With nearly the entire soft cap raised and thousands of investors already on board, this project shows all the signs of becoming the next 100x+ crypto success story. Unlike hype-driven tokens, BlockchainFX offers a real product, powerful tokenomics, and a rapidly growing global community that is fueling its momentum.

The presale price of $0.021 won’t last long, and once it launches at $0.05, early buyers will already see massive gains. Add in daily staking rewards, instant trading features, and strong security audits, and it’s clear BlockchainFX is set to disrupt the market. Don’t wait for FOMO to take over, secure your $BFX today and lock in your position before the opportunity is gone.

Buy BFX today, apply code AUG35, and unlock +35% extra tokens before the presale ends.

Website: https://blockchainfx.com/ 

X: https://x.com/BlockchainFXcom

Telegram Chat:https://t.me/blockchainfx_chat

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23